Targeting the mitochondria in chronic respiratory diseases
Dinesh Kumar Chellappan(Ajman University), Kamal Dua(University of Technology Sydney), Samantha Sert Qi Khoo(IMU University), Vyoma K. Patel(University of Technology Sydney), Keshav Raj Paudel(University of Technology Sydney), Su Min Seow(IMU University), Mayuren Candasamy(IMU University), Brian G. Oliver(University of Technology Sydney), Philip M. Hansbro(University of Technology Sydney), Jestin Chellian(Universiti Brunei Darussalam), Ka Seng Cheong(IMU University), Nian Wan Tan(IMU University), Gaurav Gupta(Gyan Vihar University), Pankaj Kumar Singh(National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad), Poonam Arora(Shree Guru Gobind Singh Tricentenary University), Sachin Kumar Singh(Lovely Professional University)
Cited by 41
Related Papers
Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention
|Diabetes & Metabolic Syndrome Clinical Research & Reviews|2018|444
Microbiome effects on immunity, health and disease in the lung
|Clinical & Translational Immunology|2017|282
Artificial Intelligence in Pharmaceutical and Healthcare Research
|Big Data and Cognitive Computing|2023|230
Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2021|198
Animal and translational models of SARS-CoV-2 infection and COVID-19
|Mucosal Immunology|2020|191